Optiver Holding B.V. Travere Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $2.48 Billion
- Q1 2025
A detailed history of Optiver Holding B.V. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 404 shares of TVTX stock, worth $6,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
404Holding current value
$6,039% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
239Shares Held
99.9MCall Options Held
1.79MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$133 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$114 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$113 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$75 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$71.7 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $959M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...